P53 and Aging: A Fresh Look at an Old Paradigm

Overview

Journal Aging (Albany NY)

Specialty Geriatrics

Date 2010 Jul 27

PMID 20657036

Citations 29

Authors

Masha V Poyurovsky

Carol Prives

Affiliations

Soon will be listed here.

Citing Articles

Haploinsufficiency of dramatically extends the lifespan of Sirt6-deficient mice.

Ghosh S, Wong S, Jiang Z, Liu B, Wang Y, Hao Q Elife. 2018; 7.

PMID: 29474172 PMC: 5825207. DOI: 10.7554/eLife.32127.

Relevance of the p53-MDM2 axis to aging.

Wu D, Prives C Cell Death Differ. 2017; 25(1):169-179.

PMID: 29192902 PMC: 5729541. DOI: 10.1038/cdd.2017.187.

Dysfunction of the MDM2/p53 axis is linked to premature aging.

Lessel D, Wu D, Trujillo C, Ramezani T, Lessel I, Alwasiyah M J Clin Invest. 2017; 127(10):3598-3608.

PMID: 28846075 PMC: 5617664. DOI: 10.1172/JCI92171.

The role of the p53 tumor suppressor in metabolism and diabetes.

Kung C, Murphy M J Endocrinol. 2016; 231(2):R61-R75.

PMID: 27613337 PMC: 5148674. DOI: 10.1530/JOE-16-0324.

Nuclear DNA damage signalling to mitochondria in ageing.

Fang E, Scheibye-Knudsen M, Chua K, Mattson M, Croteau D, Bohr V Nat Rev Mol Cell Biol. 2016; 17(5):308-21.

PMID: 26956196 PMC: 5161407. DOI: 10.1038/nrm.2016.14.

References

Matheu A, Maraver A, Klatt P, Flores I, Garcia-Cao I, Borras C . Delayed ageing through damage protection by the Arf/p53 pathway. Nature. 2007; 448(7151):375-9. DOI: 10.1038/nature05949. View

Armata H, Garlick D, Sluss H . The ataxia telangiectasia-mutated target site Ser18 is required for p53-mediated tumor suppression. Cancer Res. 2007; 67(24):11696-703. DOI: 10.1158/0008-5472.CAN-07-1610. View

Hands S, Proud C, Wyttenbach A . mTOR's role in ageing: protein synthesis or autophagy?. Aging (Albany NY). 2010; 1(7):586-97. PMC: 2806042. DOI: 10.18632/aging.100070. View

Aoki M, Jiang H, Vogt P . Proteasomal degradation of the FoxO1 transcriptional regulator in cells transformed by the P3k and Akt oncoproteins. Proc Natl Acad Sci U S A. 2004; 101(37):13613-7. PMC: 518802. DOI: 10.1073/pnas.0405454101. View

Kenyon C . The plasticity of aging: insights from long-lived mutants. Cell. 2005; 120(4):449-60. DOI: 10.1016/j.cell.2005.02.002. View

Bode A, Dong Z . Post-translational modification of p53 in tumorigenesis. Nat Rev Cancer. 2004; 4(10):793-805. DOI: 10.1038/nrc1455. View

Levine A, Feng Z, Mak T, You H, Jin S . Coordination and communication between the p53 and IGF-1-AKT-TOR signal transduction pathways. Genes Dev. 2006; 20(3):267-75. DOI: 10.1101/gad.1363206. View

Fu W, Ma Q, Chen L, Li P, Zhang M, Ramamoorthy S . MDM2 acts downstream of p53 as an E3 ligase to promote FOXO ubiquitination and degradation. J Biol Chem. 2009; 284(21):13987-4000. PMC: 2682847. DOI: 10.1074/jbc.M901758200. View

Suzuki S, Tanaka T, Poyurovsky M, Nagano H, Mayama T, Ohkubo S . Phosphate-activated glutaminase (GLS2), a p53-inducible regulator of glutamine metabolism and reactive oxygen species. Proc Natl Acad Sci U S A. 2010; 107(16):7461-6. PMC: 2867754. DOI: 10.1073/pnas.1002459107. View

10.

Ogawara Y, Kishishita S, Obata T, Isazawa Y, Suzuki T, Tanaka K . Akt enhances Mdm2-mediated ubiquitination and degradation of p53. J Biol Chem. 2002; 277(24):21843-50. DOI: 10.1074/jbc.M109745200. View

11.

Feng Z, Hu W, Teresky A, Hernando E, Cordon-Cardo C, Levine A . Declining p53 function in the aging process: a possible mechanism for the increased tumor incidence in older populations. Proc Natl Acad Sci U S A. 2007; 104(42):16633-8. PMC: 2034252. DOI: 10.1073/pnas.0708043104. View

12.

Hu W, Zhang C, Wu R, Sun Y, Levine A, Feng Z . Glutaminase 2, a novel p53 target gene regulating energy metabolism and antioxidant function. Proc Natl Acad Sci U S A. 2010; 107(16):7455-60. PMC: 2867677. DOI: 10.1073/pnas.1001006107. View

13.

Bensaad K, Cheung E, Vousden K . Modulation of intracellular ROS levels by TIGAR controls autophagy. EMBO J. 2009; 28(19):3015-26. PMC: 2736014. DOI: 10.1038/emboj.2009.242. View

14.

Vassilev L . Small-molecule antagonists of p53-MDM2 binding: research tools and potential therapeutics. Cell Cycle. 2004; 3(4):419-21. View

15.

Moumen A, Patane S, Porras A, Dono R, Maina F . Met acts on Mdm2 via mTOR to signal cell survival during development. Development. 2007; 134(7):1443-51. DOI: 10.1242/dev.02820. View

16.

Mendrysa S, OLeary K, McElwee M, Michalowski J, Eisenman R, Powell D . Tumor suppression and normal aging in mice with constitutively high p53 activity. Genes Dev. 2006; 20(1):16-21. PMC: 1356096. DOI: 10.1101/gad.1378506. View

17.

Demidenko Z, Korotchkina L, Gudkov A, Blagosklonny M . Paradoxical suppression of cellular senescence by p53. Proc Natl Acad Sci U S A. 2010; 107(21):9660-4. PMC: 2906905. DOI: 10.1073/pnas.1002298107. View

18.

Pinkston J, Garigan D, Hansen M, Kenyon C . Mutations that increase the life span of C. elegans inhibit tumor growth. Science. 2006; 313(5789):971-5. DOI: 10.1126/science.1121908. View

19.

Campisi J . Aging, tumor suppression and cancer: high wire-act!. Mech Ageing Dev. 2004; 126(1):51-8. DOI: 10.1016/j.mad.2004.09.024. View

20.

Johnson F, Sinclair D, Guarente L . Molecular biology of aging. Cell. 1999; 96(2):291-302. DOI: 10.1016/s0092-8674(00)80567-x. View